146 related articles for article (PubMed ID: 8761842)
1. Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.
Böhlen L; Bienz R; Doser M; Papiri M; Shaw S; Riesen W; Weidmann P
J Cardiovasc Pharmacol; 1996 Jun; 27(6):770-6. PubMed ID: 8761842
[TBL] [Abstract][Full Text] [Related]
2. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients.
Thürig C; Böhlen L; Schneider M; de Courten M; Shaw SG; Riesen W; Weidmann P
Eur J Clin Pharmacol; 1995; 49(1-2):21-6. PubMed ID: 8751016
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Fogari R; Zoppi A; Lazzari P; Preti P; Mugellini A; Corradi L; Lusardi P
J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930
[TBL] [Abstract][Full Text] [Related]
4. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients.
Bak JF; Gerdes LU; Sørensen NS; Pedersen O
Am J Med; 1992 Apr; 92(4B):69S-72S. PubMed ID: 1580283
[TBL] [Abstract][Full Text] [Related]
5. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.
Middeke M; Krone W
J Cardiovasc Pharmacol; 1994 Apr; 23(4):629-31. PubMed ID: 7516014
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
Oksa A; Gajdos M; Fedelesová V; Spustová V; Dzúrik R
J Cardiovasc Pharmacol; 1994 Jan; 23(1):79-86. PubMed ID: 7511740
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
Derosa G; Cicero AF; Ciccarelli L; Fogari R
Clin Ther; 2003 Jul; 25(7):2006-21. PubMed ID: 12946547
[TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril.
New JP; Bilous RW; Walker M
Diabet Med; 2000 Feb; 17(2):134-40. PubMed ID: 10746484
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents.
Lerch M; Teuscher AU; Beissner P; Schneider M; Shaw SG; Weidmann P
J Cardiovasc Pharmacol; 1998 Apr; 31(4):576-80. PubMed ID: 9554807
[TBL] [Abstract][Full Text] [Related]
10. Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.
Huang SS; Wu TC; Lin SJ; Chen JW
Circ J; 2009 Dec; 73(12):2282-7. PubMed ID: 19789415
[TBL] [Abstract][Full Text] [Related]
11. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
Fliser D; Rett K; Hübinger A; Ritz E
Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.
Striffler JS; Bhathena SJ; Michaelis OE; Campbell JD; Hansen CT; Scalbert E; Thibault N; Velasquez MT
Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A
Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159
[TBL] [Abstract][Full Text] [Related]
14. ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group.
Overlack A; Adamczak M; Bachmann W; Bönner G; Bretzel RG; Derichs R; Krone W; Lederle RM; Reimann HJ; Zschiedrich H
Am J Med; 1994 Aug; 97(2):126-34. PubMed ID: 8059778
[TBL] [Abstract][Full Text] [Related]
15. Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril.
Allemann Y; Baumann S; Jost M; Ferrari P; Shaw S; Riesen W; Weidmann P
Eur J Clin Pharmacol; 1992; 42(3):275-80. PubMed ID: 1533588
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
17. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.
Alcocer L; Campos C; Bahena JH; Nacaud A; Parra Carillo J; Calvo C; Weber C; Lerebours G; Mickalonis L; Villahermosa MT
Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353
[TBL] [Abstract][Full Text] [Related]
18. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A
Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension.
de Courten M; Ferrari P; Schneider M; Böhlen L; Shaw S; Riesen W; Heynen G; Weidmann P
Eur J Clin Pharmacol; 1993; 44(5):457-62. PubMed ID: 8359183
[TBL] [Abstract][Full Text] [Related]
20. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
